中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
8期
175-176,179
,共3页
帕金森病%滋肾益髓方%中药
帕金森病%滋腎益髓方%中藥
파금삼병%자신익수방%중약
Parkinson's disease%Invigorating the kidney and marrow%Medicine
目的:分析滋肾益髓方在治疗帕金森运动及非运动症状中的临床效果。方法将2011年6月—2013年12月该院门诊及住院部收治的60例帕金森患者作为观察对象,根据随机数表法分为观察组和对照组各30例。对照组给予抗帕金森病治疗,观察组在对照组的基础上加用滋肾益髓方,观察两组患者入组时、治疗1个月、3个月不同时点的帕金森运动功能评定量表和非运动症状筛查表。结果两组入组时,两个得分情况比较,差异无统计学意义(P>0.05);治疗前后比较:对照组治疗1月后MDRSPD得分情况与治疗前比较,差异无统计学意义(P>0.05),治疗3月后MDRSPD得分情况与治疗前比较,差异有统计学意义((P<0.05)。治疗组治疗1.3个月MDRSPD得分情况与治疗前比较,差异有统计学意义(P<0.05);组间比较:治疗组与对照姐在治疗1、3个月后MDRSPD得分情况比较,差异有统计学意义((P<0.05);观察组与对照组在治疗3个月后,非运动症状30题得分差异有统计学意义(P<0.05);观察组入组时、治疗1、3个月后非运动症状30题得分差异有统计学意义(P<0.05)。结论滋肾益髓方在帕金森病运动及非运动症状中具有一定的效果,值得借鉴。
目的:分析滋腎益髓方在治療帕金森運動及非運動癥狀中的臨床效果。方法將2011年6月—2013年12月該院門診及住院部收治的60例帕金森患者作為觀察對象,根據隨機數錶法分為觀察組和對照組各30例。對照組給予抗帕金森病治療,觀察組在對照組的基礎上加用滋腎益髓方,觀察兩組患者入組時、治療1箇月、3箇月不同時點的帕金森運動功能評定量錶和非運動癥狀篩查錶。結果兩組入組時,兩箇得分情況比較,差異無統計學意義(P>0.05);治療前後比較:對照組治療1月後MDRSPD得分情況與治療前比較,差異無統計學意義(P>0.05),治療3月後MDRSPD得分情況與治療前比較,差異有統計學意義((P<0.05)。治療組治療1.3箇月MDRSPD得分情況與治療前比較,差異有統計學意義(P<0.05);組間比較:治療組與對照姐在治療1、3箇月後MDRSPD得分情況比較,差異有統計學意義((P<0.05);觀察組與對照組在治療3箇月後,非運動癥狀30題得分差異有統計學意義(P<0.05);觀察組入組時、治療1、3箇月後非運動癥狀30題得分差異有統計學意義(P<0.05)。結論滋腎益髓方在帕金森病運動及非運動癥狀中具有一定的效果,值得藉鑒。
목적:분석자신익수방재치료파금삼운동급비운동증상중적림상효과。방법장2011년6월—2013년12월해원문진급주원부수치적60례파금삼환자작위관찰대상,근거수궤수표법분위관찰조화대조조각30례。대조조급여항파금삼병치료,관찰조재대조조적기출상가용자신익수방,관찰량조환자입조시、치료1개월、3개월불동시점적파금삼운동공능평정량표화비운동증상사사표。결과량조입조시,량개득분정황비교,차이무통계학의의(P>0.05);치료전후비교:대조조치료1월후MDRSPD득분정황여치료전비교,차이무통계학의의(P>0.05),치료3월후MDRSPD득분정황여치료전비교,차이유통계학의의((P<0.05)。치료조치료1.3개월MDRSPD득분정황여치료전비교,차이유통계학의의(P<0.05);조간비교:치료조여대조저재치료1、3개월후MDRSPD득분정황비교,차이유통계학의의((P<0.05);관찰조여대조조재치료3개월후,비운동증상30제득분차이유통계학의의(P<0.05);관찰조입조시、치료1、3개월후비운동증상30제득분차이유통계학의의(P<0.05)。결론자신익수방재파금삼병운동급비운동증상중구유일정적효과,치득차감。
Objective To analyze the invigorating the kidney and marrow in the treatment of Parkinson's symptoms and clinical ef-fects of exercise in. Methods June 2011 December 2013 outpatient and inpatient hospital treated 60 cases of Parkinson's patients as the observed object, according to a random number table divided into observation group and control group of 30 cases. The con-trol group received anti-Parkinson's disease treatment, observation group on the basis of the control group when the plus side ney marrow, were observed in patients enrolled in the treatment one month, three months at different time points Parkinson motor func-tion assessment scale and non-motor symptoms screening table. Results The two groups into the group, there was no difference be-tween the two scores (P>0.05); before and after treatment:the control group in January after two scores before and after treatment showed no difference (P>0.05), treatment in March after the two scores are different (P<0.05) compared with before treatment. 1.3-month treatment group were significantly different (P<0.05) and the treatment of the first two scores compare;comparison between groups:the treatment group and the control sister there are differences in the treatment of 1.3 months after the two scores (P<0.05);observation group and control group after three months of treatment, non-motor symptoms to score 30 questions difference was sta-tistically significant (P<0.05);the observation group into groups 1 and 3 months after treatment of non-motor symptoms to score 30 questions the difference was statistically significant (P<0.05). Conclusion Invigorating the kidney and marrow has a certain effect in Parkinson's disease movement and non-motor symptoms, it is worth learning from.